Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?

Franczyk, Beata; Rysz, Jacek; Milonski, Jaroslaw; Konecki, Tomasz; Rysz-Górzynska, Magdalena; Gluba-Brzózka, Anna.

Afiliação

Franczyk B; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland.
Rysz J; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland.
Milonski J; Department of Otolaryngology, Laryngological Oncology, Audiology and Phoniatrics, Medical University of Lodz, 90-549 Lodz, Poland.
Konecki T; Department of Urology, Medical University of Lodz, 90-549 Lodz, Poland.
Rysz-Górzynska M; Department of Ophthalmology and Visual Rehabilitation, Medical University of Lodz, 90-549 Lodz, Poland.
Gluba-Brzózka A; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland.

Pharmaceuticals (Basel) ; 15(6)2022 Jun 13.

Article em En | MEDLINE | ID: mdl-35745658